Molecular psychiatry of zebrafish

Molecular Psychiatry

Volumn 20, Issue 1, 2015, Pages 2-17

  Stewart, A M ^a,b   Ullmann, J F P ^b,c   Norton, W H J ^b,d   Parker, M O ^e   Brennan, C H ^e   Gerlai, R ^f   Kalueff, A V ^a,b,g  

^a ZENEREI Institute ZNRC   (United States)

^b The International Zebrafish Neuroscience Research Consortium   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

^g GUANGDONG OCEAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSION; ALCOHOLISM; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; HIGH THROUGHPUT SCREENING; IN VIVO STUDY; MOLECULAR BIOLOGY; NEUROIMAGING; NEUROPSYCHIATRY; NEUROSCIENCE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE; ZEBRA FISH; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE MODEL; GENETICS; MENTAL DISEASE; PATHOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; MENTAL DISORDERS; TRANSLATIONAL MEDICAL RESEARCH; ZEBRAFISH;

EID: 84908351502     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.128     Document Type: Review

References (235)

1. WHO. The Global Burden of Disease: 2004 Update. WHO (World Health Organization): Geneva, Switzerland, 2008.
2. Griebel G, Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov 2013; 12: 667-687.
3. Gonzales ML, LaSalle JM. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 2010; 12: 127-134.
4. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44: 1365-1369.
5. Mitchell K. The miswired brain: making connections from neurodevelopment to psychopathology. BMC Biol 2011; 9: 23.
6. Duman RS, Heninger GR, Nestler EJ. Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress-and druginduced neural plasticity. J Nerv Ment Dis 1994; 182: 692-700.
7. Nestler EJ. The origins of molecular psychiatry. J Mol Psychiatry 2013; 1: 3.
8. Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res 2007; 179: 1-18.
9. Kalueff AV, Echevarria DJ, Stewart AM. Gaining translational momentum: More zebrafish models for neuroscience research. Progr Neuropsychopharmacol Biol Psychiatry 2014 pii S0278-5846: 00037-2.
10. Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 2014; 35: 63-75.
11. Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 2014; 37: 264-278.
12. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013; 496: 498-503.
13. Zu Y, Tong X, Wang Z, Liu D, Pan R, Li Z et al. TALEN-mediated precise genome modification by homologous recombination in zebrafish. Nat Methods 2013; 10: 329-331.
14. Kaslin J, Panula P. Comparative anatomy of the histaminergic and other aminergic systems in the zebrafish (Danio rerio). J Comp Neurol 2001; 440: 342-377.
15. Sallinen V, Sundvik M, Reenila I, Peitsaro N, Khrustalyov D, Anichtchik O et al. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 2009; 109: 403-415.
16. Sundvik M, Panula P. Organization of the histaminergic system in adult zebrafish (Danio rerio) brain: neuron number, location, and cotransmitters. J Comp Neurol 2012; 520: 3827-3845.
17. Maximino C, Herculano AM. A review of monoaminergic neuropsychopharmacology in zebrafish. Zebrafish 2010; 7: 359-378.
18. Filippi A, Mueller T, Driever W. Vglut2 and gad expression reveal distinct patterns of dual GABAergic versus glutamatergic cotransmitter phenotypes of dopaminergic and noradrenergic neurons in the zebrafish brain. J Comp Neurol 2014; 522: 2019-2037.
19. Higashijima S, Mandel G, Fetcho JR. Distribution of prospective glutamatergic, glycinergic, and GABAergic neurons in embryonic and larval zebrafish. J Comp Neurol 2004; 480: 1-18.
20. Haug MF, Gesemann M, Mueller T, Neuhauss SC. Phylogeny and expression divergence of metabotropic glutamate receptor genes in the brain of zebrafish (Danio rerio). J Comp Neurol 2013; 521: 1533-1560.
21. Rico EP, de Oliveira DL, Rosemberg DB, Mussulini BH, Bonan CD, Dias RD et al. Expression and functional analysis of Na(+)-dependent glutamate transporters from zebrafish brain. Brain Res Bull 2010; 81: 517-523.
22. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8: 721-737, 715.
23. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25: 1-27.
24. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2012; 69: 750-753.
25. Mueller T, Guo S. The distribution of GAD67-mRNA in the adult zebrafish (teleost) forebrain reveals a prosomeric pattern and suggests previously unidentified homologies to tetrapods. J Comp Neurol 2009; 516: 553-568.
26. Delgado L, Schmachtenberg O. Immunohistochemical localization of GABA, GAD65, and the receptor subunits GABAAalpha1 and GABAB1 in the zebrafish cerebellum. Cerebellum 2008; 7: 444-450.
27. Doldan MJ, Prego B, Holmqvist BI, de Miguel E. Distribution of GABAimmunolabeling in the early zebrafish (Danio rerio) brain. Eur J Morphol 1999; 37: 126-129.
28. Mueller T, Vernier P, Wullimann MF. A phylotypic stage in vertebrate brain development: GABA cell patterns in zebrafish compared with mouse. J Comp Neurol 2006; 494: 620-634.
29. Kim YJ, Nam RH, Yoo YM, Lee CJ. Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio). Neurosci Lett 2004; 355: 29-32.
30. McLean DL, Fetcho JR. Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish. J Comp Neurol 2004; 480: 38-56.
31. Rink E, Wullimann MF. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 2001; 889: 316-330.
32. Yamamoto K, Ruuskanen JO, Wullimann MF, Vernier P. Two tyrosine hydroxylase genes in vertebrates New dopaminergic territories revealed in the zebrafish brain. Mol Cell Neurosci 2010; 43: 394-402.
33. Holzschuh J, Ryu S, Aberger F, Driever W. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 2001; 101: 237-243.
34. Yamamoto K, Ruuskanen JO, Wullimann MF, Vernier P. Differential expression of dopaminergic cell markers in the adult zebrafish forebrain. J Comp Neurol 2011; 519: 576-598.
35. Boehmler W, Obrecht-Pflumio S, Canfield V, Thisse C, Thisse B, Levenson R. Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. Dev Dyn 2004; 230: 481-493.
36. Li P, Shah S, Huang L, Carr AL, Gao Y, Thisse C et al. Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor. Dev Dyn 2007; 236: 1339-1346.
37. Tay TL, Ronneberger O, Ryu S, Nitschke R, Driever W. Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nat Commun 2011; 2: 171.
38. Ma PM. Catecholaminergic systems in the zebrafish. I. Number, morphology, and histochemical characteristics of neurons in the locus coeruleus. J Comp Neurol 1994; 344: 242-255.
39. Ma PM. Catecholaminergic systems in the zebrafish. II. Projection pathways and pattern of termination of the locus coeruleus. J Comp Neurol 1994; 344: 256-269.
40. Schweitzer J, Lohr H, Filippi A, Driever W. Dopaminergic and noradrenergic circuit development in zebrafish. Dev Neurobiol 2012; 72: 256-268.
41. Peitsaro N, Sundvik M, Anichtchik OV, Kaslin J, Panula P. Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem Pharmacol 2007; 73: 1205-1214.
42. Eriksson KS, Peitsaro N, Karlstedt K, Kaslin J, Panula P. Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neurosci 1998; 10: 3799-3812.
43. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151-162.
44. Norton WH, Folchert A, Bally-Cuif L. Comparative analysis of serotonin receptor (HTR1A/HTR1B families) and transporter (slc6a4a/b) gene expression in the zebrafish brain. J Comp Neurol 2008; 511: 521-542.
45. Schneider H, Fritzky L, Williams J, Heumann C, Yochum M, Pattar K et al. Cloning and expression of a zebrafish 5-HT(2C) receptor gene. Gene 2012; 502: 108-117.
46. Sallinen V, Sundvik M, Reenila I, Peitsaro N, Khrustalyov D, Anichtchik O et al. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 2009; 109: 403-415.
47. Lillesaar C, Stigloher C, Tannhauser B, Wullimann MF, Bally-Cuif L. Axonal projections originating from raphe serotonergic neurons in the developing and adult zebrafish, Danio rerio, using transgenics to visualize raphe-specific pet1 expression. J Comp Neurol 2009; 512: 158-182.
48. Drapeau P, Saint-Amant L, Buss RR, Chong M, McDearmid JR, Brustein E. Development of the locomotor network in zebrafish. Prog Neurobiol 2002; 68: 85-111.
49. Rink E, Guo S. The too few mutant selectively affects subgroups of monoaminergic neurons in the zebrafish forebrain. Neuroscience 2004; 127: 147-154.
50. Teraoka H, Russell C, Regan J, Chandrasekhar A, Concha ML, Yokoyama R et al. Hedgehog and Fgf signaling pathways regulate the development of tphRexpressing serotonergic raphe neurons in zebrafish embryos. J Neurobiol 2004; 60: 275-288.
51. Bellipanni G, Rink E, Bally-Cuif L. Cloning of two tryptophan hydroxylase genes expressed in the diencephalon of the developing zebrafish brain. Mech Dev 2002; 119 Suppl 1: S215-S220.
52. Wang Y, Takai R, Yoshioka H, Shirabe K. Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med 2006; 208: 267-274.
53. Yamamoto K, Vernier P. The evolution of dopamine systems in chordates. Front Neuroanat 2011; 5: 21.
54. Lillesaar C. The serotonergic system in fish. J Chem Neuroanat 2011; 41: 294-308.
55. Hsieh DJ, Liao CF. Zebrafish M2 muscarinic acetylcholine receptor: cloning, pharmacological characterization, expression patterns and roles in embryonic bradycardia. Br J Pharmacol 2002; 137: 782-792.
56. Papke RL, Ono F, Stokes C, Urban JM, Boyd RT. The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study. Biochem Pharmacol 2012; 84: 352-365.
57. Klee EW, Schneider H, Clark KJ, Cousin MA, Ebbert JO, Hooten WM et al. Zebrafish: a model for the study of addiction genetics. Hum Genet 2012; 131: 977-1008.
58. Arenzana FJ, Clemente D, Sanchez-Gonzalez R, Porteros n, Aijon J, Arevalo R. Development of the cholinergic system in the brain and retina of the zebrafish. Brain Res Bull 2005; 66: 421-425.
59. Clemente D, Porteros A, Weruaga E, Alonso JR, Arenzana FJ, Aijun J et al. Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysis. J Comp Neurol 2004; 474: 75-107.
60. Postlethwait JH, Yan YL, Gates MA, Horne S, Amores A, Brownlie A et al. Vertebrate genome evolution and the zebrafish gene map. Nat Genet 1998; 18: 345-349.
61. Fredriksson R, Schioth HB. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 2005; 67: 1414-1425.
62. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010; 40: 46-57.
63. Ruuskanen JO, Xhaard H, Marjamaki A, Salaneck E, Salminen T, Yan YL et al. Identification of duplicated fourth alpha2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish. Mol Biol Evol 2004; 21: 14-28.
64. Ruuskanen JO, Laurila J, Xhaard H, Rantanen VV, Vuoriluoto K, Wurster S et al. Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors. Br J Pharmacol 2005; 144: 165-177.
65. Ruuskanen JO, Peitsaro N, Kaslin JV, Panula P, Scheinin M. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. J Neurochem 2005; 94: 1559-1569.
66. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 2008; 26: 702-708.
67. Moens CB, Donn TM, Wolf-Saxon ER, Ma TP. Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic 2008; 7: 454-459.
68. Peravali R, Gehrig J, Giselbrecht S, Lutjohann DS, Hadzhiev Y, Muller F et al. Automated feature detection and imaging for high-resolution screening of zebrafish embryos. Biotechniques 2011; 50: 319-324.
69. Pardo-Martin C, Chang TY, Koo BK, Gilleland CL, Wasserman SC, Yanik MF. Highthroughput in vivo vertebrate screening. Nat Methods 2010; 7: 634-636.
70. Akerboom J, Chen TW, Wardill TJ, Tian L, Marvin JS, Mutlu S et al. Optimization of a GCaMP calcium indicator for neural activity imaging. J Neurosci 2012; 32: 13819-13840.
71. Scott EK, Mason L, Arrenberg AB, Ziv L, Gosse NJ, Xiao T et al. Targeting neural circuitry in zebrafish using GAL4 enhancer trapping. Nat Methods 2007; 4: 323-326.
72. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell 2004; 7: 133-144.
73. Ahrens MB, Orger MB, Robson DN, Li JM, Keller PJ. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat Methods 2013; 10: 413-420.
74. Kubo F, Hablitzel B, Dal Maschio M, Driever W, Baier H, Arrenberg AB. Functional architecture of an optic flow-responsive area that drives horizontal eye movements in zebrafish. Neuron 2014; 81: 1344-1359.
75. Huang KH, Ahrens MB, Dunn TW, Engert F. Spinal projection neurons control turning behaviors in zebrafish. Curr Biol 2013; 23: 1566-1573.
76. Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci 2012; 13: 251-266.
77. Pan YA, Livet J, Sanes JR, Lichtman JW, Schier AF. Multicolor Brainbow imaging in zebrafish. Cold Spring Harb Protoc 2011; 2011pdb prot5546.
78. Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci 2011; 15: 409-416.
79. Weinberger DR. From neuropathology to neurodevelopment. Lancet 1995; 346: 552-557.
80. Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 2007; 450: 56-62.
81. Cai D, Cohen KB, Luo T, Lichtman JW, Sanes JR. Improved tools for the Brainbow toolbox. Nat Methods 2013; 10: 540-547.
82. Pan YA, Freundlich T, Weissman TA, Schoppik D, Wang XC, Zimmerman S et al. Zebrabow: multispectral cell labeling for cell tracing and lineage analysis in zebrafish. Development 2013; 140: 2835-2846.
83. Gubernator NG, Zhang H, Staal RG, Mosharov EV, Pereira DB, Yue M et al. Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals. Science 2009; 324: 1441-1444.
84. Rodriguez PC, Pereira DB, Borgkvist A, Wong MY, Barnard C, Sonders MS et al. Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain. Proc Natl Acad Sci USA 2013; 110: 870-875.
85. Okubo Y, Sekiya H, Namiki S, Sakamoto H, Iinuma S, Yamasaki M et al. Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci USA 2010; 107: 6526-6531.
86. Marvin JS, Borghuis BG, Tian L, Cichon J, Harnett MT, Akerboom J et al. An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat Methods 2013; 10: 162-170.
87. Nguyen QT, Schroeder LF, Mank M, Muller A, Taylor P, Griesbeck O et al. An in vivo biosensor for neurotransmitter release and in situ receptor activity. Nat Neurosci 2010; 13: 127-132.
88. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008; 2: 183-189.
89. Dodt H-U, Leischner U, Schierloh A, Jahrling N, Mauch CP, Deininger K et al. Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain. Nat Methods 2007; 4: 331-336.
90. Erturk A, Mauch CP, Hellal F, Forstner F, Keck T, Becker K et al. Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury. Nat Med 2012; 18: 166-171.
91. Hama H, Kurokawa H, Kawano H, Ando R, Shimogori T, Noda H et al. Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat Neurosci 2011; 14: 1481-1488.
92. Erturk A, Becker K, Jahrling N, Mauch CP, Hojer CD, Egen JG et al. Threedimensional imaging of solvent-cleared organs using 3DISCO. Nat Protoc 2012; 7: 1983-1995.
93. Chung K, Wallace J, Kim SY, Kalyanasundaram S, Andalman AS, Davidson TJ et al. Structural and molecular interrogation of intact biological systems. Nature 2013; 497: 332-337.
94. Ke MT, Fujimoto S, Imai T. SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction. Nat Neurosci 2013; 16: 1154-1161.
95. Kuwajima T, Sitko AA, Bhansali P, Jurgens C, Guido W, Mason C. ClearT: a detergent-and solvent-free clearing method for neuronal and nonneuronal tissue. Development 2013; 140: 1364-1368.
96. Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM et al. Wholebrain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell 2014; 157: 726-739.
97. Seo HC, Saetre BO, Havik B, Ellingsen S, Fjose A. The zebrafish Pax3 and Pax7 homologues are highly conserved, encode multiple isoforms and show dynamic segment-like expression in the developing brain. Mech Dev 1998; 70: 49-63.
98. Moore S, Ribes V, Terriente J, Wilkinson D, Relaix F, Briscoe J. Distinct regulatory mechanisms act to establish and maintain Pax3 expression in the developing neural tube. PLoS Genet 2013; 9: e1003811.
99. Garnett AT, Square TA, Medeiros DM. BMP, Wnt and FGF signals are integrated through evolutionarily conserved enhancers to achieve robust expression of Pax3 and Zic genes at the zebrafish neural plate border. Development 2012; 139: 4220-4231.
100. Fernandes AM, Beddows E, Filippi A, Driever W. Orthopedia transcription factor otpa and otpb paralogous genes function during dopaminergic and neuroendocrine cell specification in larval zebrafish. PLoS ONE 2013; 8: e75002.
101. Ryu S, Mahler J, Acampora D, Holzschuh J, Erhardt S, Omodei D et al. Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr Biol: CB 2007; 17: 873-880.
102. Kastenhuber E, Kratochwil CF, Ryu S, Schweitzer J, Driever W. Genetic dissection of dopaminergic and noradrenergic contributions to catecholaminergic tracts in early larval zebrafish. J Comp Neurol 2010; 518: 439-458.
103. Zhang P, Hirsch EC, Damier P, Duyckaerts C, Javoy-Agid F. c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease. Neuroscience 1992; 46: 9-21.
104. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 2007; 31: 18-40.
105. Singewald N, Salchner P, Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003; 53: 275-283.
106. Baraban SC, Taylor MR, Castro PA, Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005; 131: 759-768.
107. Ellis LD, Seibert J, Soanes KH. Distinct models of induced hyperactivity in zebrafish larvae. Brain Res 2012; 1449: 46-59.
108. Cachat J, Kyzar EJ, Collins C, Gaikwad S, Green J, Roth A et al. Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Behav Brain Res 2013; 236: 258-269.
109. Riehl R, Kyzar E, Allain A, Green J, Hook M, Monnig L et al. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol Teratol 2011; 33: 658-667.
110. Lau BY, Mathur P, Gould GG, Guo S. Identification of a brain center whose activity discriminates a choice behavior in zebrafish. Proc Natl Acad Sci USA 2011; 108: 2581-2586.
111. von Trotha JW, Vernier P, Bally-Cuif L. Emotions and motivated behavior converge on an amygdala-like structure in the zebrafish. Eur J Neurosci 2014 (in press).
112. Virdee K, Cumming P, Caprioli D, Jupp B, Rominger A, Aigbirhio FI et al. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders. Neurosci Biobehav Rev 2012; 36: 1188-1216.
113. Arnsten AF, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 2012; 51: 356-367.
114. Mullins MC, Hammerschmidt M, Haffter P, Nüsslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 1994; 4: 189-202.
115. Amsterdam A, Burgess S, Golling G, Chen W, Sun Z, Townsend K et al. A largescale insertional mutagenesis screen in zebrafish. Genes Dev 1999; 13: 2713-2724.
116. Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE et al. Nicotine response genetics in the zebrafish. Proc Natl Acad Sci 2009; 106: 18662-18667.
117. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 2013; 31: 227-229.
118. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006; 45: 192-202.
119. Schmidt S, Petermann F. Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD). BMC Psychiatry 2009; 9: 58.
120. Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL et al. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 1998; 50: 1087-1093.
121. Arnsten AF. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 2007; 17 Suppl 1: i6-15.
122. Bush G. Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology 2010; 35: 278-300.
123. Rubia K. "Cool" inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus "hot" ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review. Biol Psychiatry 2011; 69: e69-e87.
124. Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010; 15: 1053-1066.
125. Lange M, Norton W, Coolen M, Chaminade M, Merker S, Proft F et al. The ADHDlinked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish. Mol Psychiatry 2012; 17: 855.
126. Lange M, Norton W, Coolen M, Chaminade M, Merker S, Proft F et al. The ADHDsusceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol Psychiatry 2012; 17: 946-954.
127. Tay TL, Ronneberger O, Ryu S, Nitschke R, Driever W. Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nat Commun 2011; 2: 171.
128. Lange M, Norton W, Coolen M, Chaminade M, Merker S, Proft F et al. The ADHDsusceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol Psychiatry 2012; 17: 946-954.
129. Wallis D, Hill DS, Mendez IA, Abbott LC, Finnell RH, Wellman PJ et al. Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Res 2012; 1463: 85-92.
130. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect 2010; 118: 1762-1767.
131. Spulber S, Kilian P, Wan Ibrahim WN, Onishchenko N, Ulhaq M, Norrgren L et al. PFOS induces behavioral alterations, including spontaneous hyperactivity that is corrected by dexamfetamine in zebrafish larvae. PLoS ONE 2014; 9: e94227.
132. Levin ED, Sledge D, Roach S, Petro A, Donerly S, Linney E. Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol 2011; 33: 668-673.
133. Gerlai R, Lahav M, Guo S, Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000; 67: 773-782.
134. Oliveira RF, Silva JF, Simoes JM. Fighting zebrafish: characterization of aggressive behavior and winner-loser effects. Zebrafish 2011; 8: 73-81.
135. Kalueff AV, Gebhardt M, Stewart AM, Cachat JM, Brimmer M, Chawla JS et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 2013; 10: 70-86.
136. Moretz JA, Martins EP, Robison BD. Behavioural syndromes and the evolution of correlated behavior in zebrafish. Behav Ecol 2007; 18: 1-7.
137. Filby AL, Paull GC, Hickmore TF, Tyler CR. Unravelling the neurophysiological basis of aggression in a fish model. BMC Genomics 2010; 11: 498.
138. Larson ET, O'Malley DM, Melloni RH Jr. Aggression and vasotocin are associated with dominant-subordinate relationships in zebrafish. Behav Brain Res 2006; 167: 94-102.
139. Norton WH, Stumpenhorst K, Faus-Kessler T, Folchert A, Rohner N, Harris MP et al. Modulation of Fgfr1a signaling in zebrafish reveals a genetic basis for the aggression-boldness syndrome. J Neurosci 2011; 31: 13796-13807.
140. Sneddon LU, Schmidt R, Fang Y, Cossins AR. Molecular correlates of social dominance: a novel role for ependymin in aggression. PLoS ONE 2011; 6: e18181.
141. Filby AL, Paull GC, Searle F, Ortiz-Zarragoitia M, Tyler CR. Environmental estrogen-induced alterations of male aggression and dominance hierarchies in fish: a mechanistic analysis. Environ Sci Technol 2012; 46: 3472-3479.
142. Rohner N, Bercsenyi M, Orban L, Kolanczyk ME, Linke D, Brand M et al. Duplication of fgfr1 permits Fgf signaling to serve as a target for selection during domestication. Curr Biol 2009; 19: 1642-1647.
143. Thisse B, Thisse C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 2005; 287: 390-402.
144. Caramillo EM, Khan KM, Collier AD, Echevarria DJ. Modeling PTSD in the zebrafish: Are we there yet? Behav Brain Res 2014; pii S0166-4328: 00296-4.
145. Stewart AM, Yang E, Nguyen M, Kalueff AV. Developing zebrafish models relevant to PTSD and other trauma-and stressor-related disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014; pii S0278-5846: 00153-00155.
146. Bass SL, Gerlai R. Zebrafish (Danio rerio) responds differentially to stimulus fish: the effects of sympatric and allopatric predators and harmless fish. Behav Brain Res 2008; 186: 107-117.
147. Gerlai R. Zebrafish antipredatory responses: a future for translational research? Behav Brain Res 2010; 207: 223-231.
148. Blank M, Guerim LD, Cordeiro RF, Vianna MR. A one-trial inhibitory avoidance task to zebrafish: rapid acquisition of an NMDA-dependent long-term memory. Neurobiol Learn Mem 2009; 92: 529-534.
149. Morin C, de Souza Silva MA, Muller CP, Hardigan P, Spieler RE. Active avoidance learning in zebrafish (Danio rerio)-the role of sensory modality and interstimulus interval. Behav Brain Res 2013; 248: 141-143.
150. Xu X, Scott-Scheiern T, Kempker L, Simons K. Active avoidance conditioning in zebrafish (Danio rerio). Neurobiol Learn Mem 2007; 87: 72-77.
151. Pradel G, Schmidt R, Schachner M. Involvement of L1.1 in memory consolidation after active avoidance conditioning in zebrafish. J Neurobiol 2000; 43: 389-403.
152. Agetsuma M, Aoki T, Aoki R, Okamoto H. Cued fear conditioning in zebrafish (Danio rerio). In: Kalueff AV, Stewart AM (eds). Zebrafish Protocols for Neurobehavioral Research vol. 66. Humana Press: New York, NY, pp 257-264, 2012.
153. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009; 205: 38-44.
154. Speedie N, Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behav Brain Res 2008; 188: 168-177.
155. Wong K, Elegante M, Bartels B, Elkhayat S, Tien D, Roy S et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010; 208: 450-457.
156. Mahabir S, Chatterjee D, Buske C, Gerlai R. Maturation of shoaling in two zebrafish strains: a behavioral and neurochemical analysis. Behav Brain Res 2013; 247: 1-8.
157. Miller N, Gerlai R. Quantification of shoaling behaviour in zebrafish (Danio rerio). Behav Brain Res 2007; 184: 157-166.
158. Miller NY, Gerlai R. Oscillations in shoal cohesion in zebrafish (Danio rerio). Behav Brain Res 2008; 193: 148-151.
159. Stewart AM, Nguyen M, Wong K, Poudel MK, Kalueff AV. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatry 2014; 50: 27-36.
160. Green J, Collins C, Kyzar EJ, Pham M, Roth A, Gaikwad S et al. Automated highthroughput neurophenotyping of zebrafish social behavior. J Neurosci Methods 2012; 210: 266-271.
161. Pham M, Raymond J, Hester J, Kyzar E, Gaikwad S, Bruce I et al. Assessing social behavior phenotypes in adult zebrafish: shoaling, social preference and mirror biting tests. In: Kalueff AV, Stewart AM (eds). Zebrafish Protocols for Neurobehavioral Research. Humana Press: New York, NY, 2012.
162. Hageman I, Andersen HS, Jorgensen MB. Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy. Acta Psychiatr Scand 2001; 104: 411-422.
163. Alderman SL, Bernier NJ. Ontogeny of the corticotropin-releasing factor system in zebrafish. Gen Comp Endocrinol 2009; 164: 61-69.
164. Alsop D, Vijayan M. The zebrafish stress axis: molecular fallout from the teleostspecific genome duplication event. Gen Comp Endocrinol 2009; 161: 62-66.
165. Griffiths BB, Schoonheim PJ, Ziv L, Voelker L, Baier H, Gahtan E. A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response. Front Behav Neurosci 2012; 6: 68.
166. Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA et al. An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol Psychiatry 2013; 18: 681-691.
167. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 2001; 62 Suppl 17: 41-46.
168. Chakravarty S, Reddy BR, Sudhakar SR, Saxena S, Das T, Meghah V et al. Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction. PLoS ONE 2013; 8: e63302.
169. Gotovac K, Sabioncello A, Rabatic S, Berki T, Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol 2003; 131: 335-339.
170. Schaaf MJ, Champagne D, van Laanen IH, van Wijk DC, Meijer AH, Meijer OC et al. Discovery of a functional glucocorticoid receptor -isoform in zebrafish. Endocrinology 2008; 149: 1591-1599.
171. Mehta D, Binder EB. Gene x environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology 2012; 62: 654-662.
172. Alsop D, Vijayan M. The zebrafish stress axis: molecular fallout from the teleostspecific genome duplication event. Gen Comp Endocrinol 2009; 161: 62-66.
173. Dutton MA, Lee EW, Zukowska Z. NPY and extreme stress: lessons learned from posttraumatic stress disorder. EXS 2006; 95: 213-222.
174. Nguyen M, Yang E, Neelkantan N, Mikhaylova A, Arnold R, Poudel MK et al. Developing integrative zebrafish models of behavioral and metabolic disorders. Behav Brain Res 2013; 256: 172-187.
175. Tyrka A. Biomarkers of Risk for Post-Traumatic Stress Disorder (PTSD): DTIC Document. US Army Medical Research and Materiel Command: Fort Detrick, MD, 2011; pp 1-17.
176. Alazizi A, Liu MY, Williams FE, Kurogi K, Sakakibara Y, Suiko M et al. Identification, characterization, and ontogenic study of a catechol O-methyltransferase from zebrafish. Aquat Toxicol (Amsterdam, Netherlands) 2011; 102: 18-23.
177. Aldeco M, Arslan BK, Edmondson DE. Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B. Comp Biochem Physiol B Biochem Biol 2011; 159: 78-83.
178. Mann KD, Hoyt C, Feldman S, Blunt L, Raymond A, Page-McCaw PS. Cardiac response to startle stimuli in larval zebrafish: sympathetic and parasympathetic components. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1288-R1297.
179. Robinson TE, Berridge KC. The neural basis of drug craving: an incentivesensitization theory of addiction. Brain Res Rev 1993; 18: 247-291.
180. Rink E, Wullimann MF. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 2001; 889: 316-330.
181. Rink E, Wullimann MF. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Dev Brain Res 2002; 137: 89-100.
182. Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC. Zebrafish for the study of the biological effects of nicotine. Nicotine Tob Res 2011; 13: 301-312.
183. Darland T, Dowling JE. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci USA 2001; 98: 11691-11696.
184. Ninkovic J, Folchert A, Makhankov YV, Neuhauss SC, Sillaber I, Straehle U et al. Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetamine in zebrafish. J Neurobiol 2006; 66: 463-475.
185. Kily LJ, Cowe YC, Hussain O, Patel S, McElwaine S, Cotter FE et al. Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol 2008; 211: 1623-1634.
186. Lau B, Bretaud S, Huang Y, Lin E, Guo S. Dissociation of food and opiate preference by a genetic mutation in zebrafish. Genes Brain Behav 2006; 5: 497-505.
187. Guo S, Wilson SW, Cooke S, Chitnis AB, Driever W, Rosenthal A. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol 1999; 208: 473-487.
188. Levkowitz G, Zeller J, Sirotkin HI, French D, Schilbach S, Hashimoto H et al. Zinc finger protein too few controls the development of monoaminergic neurons. Nat Neurosci 2002; 6: 28-33.
189. Lau B, Bretaud S, Huang Y, Lin E, Guo S. Dissociation of food and opiate preference by a genetic mutation in zebrafish. Genes Brain Behav 2006; 5: 497-505.
190. Webb KJ, Norton WH, Trumbach D, Meijer AH, Ninkovic J, Topp S et al. Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 2009; 10: R81.
191. Mathur P, Lau B, Guo S. Conditioned place preference behavior in zebrafish. Nat Protoc 2011; 6: 338-345.
192. Mathur P, Berberoglu MA, Guo S. Preference for ethanol in zebrafish following a single exposure. Behav Brain Res 2011; 217: 128-133.
193. Bretaud S, Li Q, Lockwood B, Kobayashi K, Lin E, Guo S. A choice behavior for morphine reveals experience-dependent drug preference and underlying neural substrates in developing larval zebrafish. Neuroscience 2007; 146: 1109-1116.
194. Ponzoni L, Braida D, Pucci L, Andrea D, Fasoli F, Manfredi I et al. The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors. Psychopharmacology 2014; 1-13 (in press).
195. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005; 8: 1481-1489.
196. Pelloux Y, Everitt BJ, Dickinson A. Compulsive drug seeking by rats under punishment: effects of drug taking history. Psychopharmacology 2007; 194: 127-137.
197. Kily LJM, Cowe YCM, Hussain O, Patel S, McElwaine S, Cotter FE et al. Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol 2008; 211: 1623-1634.
198. Brennan CH, Parmar A, Kily LKM, Ananthathevan A, Doshi A, Patel S et al. Conditioned place preference models of drug dependence and relapse to drug seeking: studies with nicotine and ethanol. Neuromethods 2011; 52: 163-180.
199. Shaham Y, Hope BT. The role of neuroadaptations in relapse to drug seeking. Nat Neurosci 2005; 8: 1437-1439.
200. Navarro HJ, Doran CM, Shakeshaft AP. Measuring costs of alcohol harm to others: a review of the literature. Drug Alcohol Depend 2011; 114: 87-99.
201. Tran S, Gerlai R. Recent advances with a novel model organism: alcohol tolerance and sensitization in zebrafish (Danio rerio). Prog Neuropsychopharmacol Biol Psychiatry 2014; pii S0278-5846: 00038-4.
202. Miller N, Greene K, Dydinski A, Gerlai R. Effects of nicotine and alcohol on zebrafish (Danio rerio) shoaling. Behav Brain Res 2013; 240: 192-196.
203. Gerlai R, Chatterjee D, Pereira T, Sawashima T, Krishnannair R. Acute and chronic alcohol dose: population differences in behavior and neurochemistry of zebrafish. Genes Brain Behav 2009; 8: 586-599.
204. Tran S, Chatterjee D, Gerlai R. An integrative analysis of ethanol tolerance and withdrawal in zebrafish (Danio rerio). Behav Brain Res 2014; pii S0166-4328: 00109-0.
205. Fernandes Y, Tran S, Abraham E, Gerlai R. Embryonic alcohol exposure impairs associative learning performance in adult zebrafish. Behav Brain Res 2014; 265: 181-187.
206. Pan Y, Kaiguo M, Razak Z, Westwood JT, Gerlai R. Chronic alcohol exposure induced gene expression changes in the zebrafish brain. Behav Brain Res 2011; 216: 66-76.
207. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65.
208. Dalley JW, Cardinal RN, Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004; 28: 771-784.
209. Urcelay GP, Dalley JW. Linking ADHD, impulsivity, and drug abuse: a neuropsychological perspective. Curr Top Behav Neurosci 2012; 9: 173-197.
210. Clayton IC, Richards JC, Edwards CJ. Selective attention in obsessive compulsive disorder. J Abnorm Psychol 1999; 108: 171.
211. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008; 320: 1352-1355.
212. Molander AC, Mar A, Norbury A, Steventon S, Moreno M, Caprioli D et al. High impulsivity predicting vulnerability to cocaine addiction in rats: some relationship with novelty preference but not novelty reactivity, anxiety or stress. Psychopharmacology 2011; 215: 721-731.
213. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011; 69: 680-694.
214. Robbins T. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 2002; 163: 362-380.
215. Economidou D, Pelloux Y, Robbins TW, Dalley JW, Everitt BJ. High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry 2009; 65: 851-856.
216. Parker MO, Millington ME, Combe FJ, Brennan CH. Development and implementation of a three-choice serial reaction time task for zebrafish (Danio rerio). Behav Brain Res 2012; 227: 73-80.
217. Parker M, Ife D, Ma J, Pancholi M, Smeraldi F, Straw C et al. Development and automation of a test of impulse control in zebrafish. Front Syst Neurosci 2013; 7: 65.
218. Parker MO, Brock AJ, Sudwarts A, Brennan CH. Atomoxetine reduces anticipatory responding in a 5-choice serial reaction time task for adult zebrafish. Psychopharmacology 2014; 231: 2671-2679.
219. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008; 33: 1028-1037.
220. Force A, Lynch M, Pickett FB, Amores A, Yan YL, Postlethwait J. Preservation of duplicate genes by complementary, degenerative mutations. Genetics 1999; 151: 1531-1545.
221. Nguyen M, Yang E, Neelkantan N, Mikhaylova A, Arnold R, Poudel MK et al. Developing 'integrative' zebrafish models of behavioral and metabolic disorders. Behav Brain Res 2013; 256: 172-187.
222. Ito H, Yamamoto N. Non-laminar cerebral cortex in teleost fishes? Biol Lett 2009; 5: 117-121.
223. Aizawa H. Habenula and the asymmetric development of the vertebrate brain. Anat Sci Int 2013; 88: 1-9.
224. Tomaiuolo M, Gonzalez C, Medina JH, Piriz J. Lateral Habenula determines longterm storage of aversive memories. Front Behav Neurosci 2014; 8: 170.
225. Agetsuma M, Aizawa H, Aoki T, Nakayama R, Takahoko M, Goto M et al. The habenula is crucial for experience-dependent modification of fear responses in zebrafish. Nat Neurosci 2010; 13: 1354-1356.
226. Amo R, Aizawa H, Takahoko M, Kobayashi M, Takahashi R, Aoki T et al. Identification of the zebrafish ventral habenula as a homolog of the mammalian lateral habenula. J Neurosci 2010; 30: 1566-1574.
227. Okamoto H, Agetsuma M, Aizawa H. Genetic dissection of the zebrafish habenula, a possible switching board for selection of behavioral strategy to cope with fear and anxiety. Dev Neurobiol 2012; 72: 386-394.
228. Shimada Y, Hirano M, Nishimura Y, Tanaka T. A high-throughput fluorescencebased assay system for appetite-regulating gene and drug screening. PLoS ONE 2012; 7: e52549.
229. Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 2013; 499: 295-300.
230. Chatterjee D, Shams S, Gerlai R. Chronic and acute alcohol administration induced neurochemical changes in the brain: comparison of distinct zebrafish populations. Amino acids 2014; 46: 921-930.
231. Hough LB. Histamine. Lippincott-Raven: Phidadelphia, 1999.
232. Gerlai R. Antipredatory behavior of zebrafish: adaptive function and a tool for translational research. Evol Psychol 2013; 11: 591-605.
233. Cachat J, Canavello P, Elegante M, Bartels B, Hart P, Bergner C et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010; 208: 371-376.
234. Chatterjee D, Gerlai R. High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish. Behav Brain Res 2009; 200: 208-213.
235. Pan Y, Chatterjee D, Gerlai R. Strain dependent gene expression and neurochemical levels in the brain of zebrafish: focus on a few alcohol related targets. Physiol Behav 2012; 107: 773-780.